AB Science S.A. (ABSCF)
Develops experimental drugs targeting nerve damage, inflammation, and cancer, with a veterinary treatment already on the market.
$1.12+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-11.1%
The outlook
AB Science is trading at its 52-week low of $1.12 with minimal analyst coverage. Price action remains choppy against moving averages, and the overall sentiment leans bearish. The stock shows little momentum in either direction at present levels.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$82.0M
52-wk high
$2.70
52-wk low
$1.12
50-day avg
$1.12
200-day avg
$1.30
Trailing P/E
—